Apr 18,2024

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution

DarioHealth announced two new contracts to provide integrated chronic condition management solutions for two employers beginning in the Q2 2024. The employers, a national supply chain company and a regional education organization, selected Dario's cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a GLP-1 medication.

PRODUCT

#dtx

#coaching

View Analyst & Ambassador Comments
Go to original news
Apr 22,2024

Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial

This RCT research aimed to compare the effects of continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) over 12 months in adults with insulin-treated type 2 diabetes. The study, conducted at Steno Diabetes Center Copenhagen, Denmark, involved 76 participants with poorly controlled type 2 diabetes. Results showed that CGM use led to significantly greater improvements compared to BGM in several key areas. These included an increase in time spent in the target glucose range, a decrease in HbA1c levels, a reduction in total daily insulin dose, weight loss, and improvements in self-rated diabetes-related health, well-being, satisfaction, and health behavior.

CLINICAL STUDY

#bgm

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 09,2024

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

Embecta Corp announced that it has submitted a 510(k) premarket filing to the U.S. Food and Drug Administration (FDA) for a proprietary disposable insulin delivery system. "This patch pump is intended for people who require insulin to manage diabetes and is informed by the unique needs of people with type 2 diabetes and their healthcare providers," said Colleen Riley, Chief Technology Officer, embecta. embecta continues to advance its patch pump development program, with plans for a closed-loop version including an insulin-dosing algorithm in a future FDA submission.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Feb 26,2024

Simple HealthKit Launches Expanded Kidney Health Evaluation for Patients with Diabetes (KED) Program to Help Payers Improve Patient Health, Boost STAR Ratings & Meet HEDIS Measures

At the ViVE 2024 Conference in Los Angeles, Simple HealthKit unveiled its new Kidney Health Evaluation for Patients with Diabetes (KED) program, aimed at helping healthcare payers enhance patient health outcomes, boost STAR ratings, and meet HEDIS measures. The program includes the Expanded Kidney Health Test, assessing kidney function and damage, available through in-clinic or at-home settings. The company's engagement platform achieves high adoption and utilization rates, supporting both in-clinic and at-home testing programs. Real-time analytics on program performance and HEDIS reporting empower decision-makers to make informed choices and identify trends.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Feb 15,2024

Season Health and The Froedtert & the Medical College of Wisconsin Health Network Announce Partnership to Leverage Food as Medicine in the Treatment of Diabetes

Season Health has partnered with the Froedtert & the Medical College of Wisconsin health network to launch a six-month program targeting patients with diabetes. This evidence-based program aims to reduce unhealthy blood sugar levels through a comprehensive food-as-medicine approach. The platform offers one-on-one clinical nutrition support, access to culturally relevant recipes, home delivery of medically-tailored meals and groceries, and ongoing nutrition education. Season's previous outcomes show significant improvements in health metrics for patients, leading to reduced healthcare utilization. The program, launching today, will provide virtual support from registered dietitians and diabetes specialists, personalized nutritional guidance, and access to healthy food options.

COLLABORATION PARTNERSHIP

#institution

#coaching

#virtual care

View Analyst & Ambassador Comments
Go to original news
Feb 07,2024

Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform

Labcorp and WeightWatchers for Business have expanded their partnership to offer Labcorp employees and their families a comprehensive weight health platform at no cost. This platform includes behavioral and clinical interventions, tailored pathways based on individual needs, access to virtual clinic care, medication management, and community coaching support. The result is an end-to-end solution covering everything from behavioral programs to access to clinical evaluations and treatment options, as well as medication management for those eligible and in need of a high-touch solution. Access to virtual clinic care and medication management for those eligible also includes GLP-1s, when appropriate, under the guidance of board-certified clinicians as well as registered dietitians, fitness specialists, and care coordinators.

COLLABORATION PARTNERSHIP

#institution

#coaching

#virtual care

View Analyst & Ambassador Comments
Go to original news
Apr 17,2024

ABBOTT REPORTS FIRST-QUARTER 2024 RESULTS AND RAISES MIDPOINT OF FULL-YEAR GUIDANCE RANGES

Abbott announced financial results for the first quarter ended March 31, 2024. Sales growth was led by double-digit growth in Diabetes Care, Electrophysiology, Neuromodulation, and Structural Heart. In Diabetes Care, FreeStyle Libre sales were $1.5 billion, which represents sales growth of 22.4 percent on a reported basis and 23.3 percent on an organic basis. The highlights mentioned in the quarterly sales announcement included Insulet's Omnipod 5 Automated Insulin Delivery System's CE Mark approval, which offers an integrated solution with Abbott's FreeStyle Libre 2 Plus sensor for treating diabetes.

View Analyst & Ambassador Comments
Go to original news
Mar 28,2024 TOP STORY

DARIOHEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 FINANCIAL AND OPERATING RESULTS

For Full Year 2023, DarioHealth reported a revenue of $20.4 million, marking a decrease from $27.7 million in 2022. This reduction was primarily due to a managed decrease in B2C and strategic milestone revenue, while core B2B2C revenue increased by 39% year over year. Commercial revenues were the main contributor, with B2B2C growing from 13% to 25% of total revenue compared to 2022. For Q4 2023, the company reported revenues of $3.6 million, a 47% decrease from the same period in 2022. However, this represented a slight increase from the previous quarter. Gross profit for Q4 2023 was $132,000, a significant decrease from $2.7 million in Q4 2022. Net loss for Q4 2023 was $14.3 million. As the company acquired Twill recently in Q1 of 2024, it is expected to significantly increase revenue and gross margins. Total pro forma non-audited revenues for the integrated entity in 2023 were approximately $38 million.

View Analyst & Ambassador Comments
Go to original news
Apr 12,2024

Lark Health Names a New Chief Growth Officer to Scale GLP-1 Cost Containment and Care Offerings

Digital chronic-condition management company Lark Health announced the appointment of Darren Eckberg as its new chief growth officer, who will lead the expansion of the company's AI-enabled GLP-1 cost-containment technology. The company offers health plans and employers technology aimed at reducing the costs associated with GLP-1s, including virtual coaching for weight management and medication adherence and provider-facing tools like insurance navigation and prior authorization obtainment. Eckberg previously held executive roles at EnvisionRx/Rite Aid, Express Scripts, Prime Therapeutics and IngenioRx/Anthem.

View Analyst & Ambassador Comments
Go to original news
Apr 11,2024

Intuity Medical is Providing Insured People with Diabetes Easier Access to POGO Automatic Through HealthHavenRx™ eCommerce Partnership

Intuity Medical is announcing a partnership with HealthHavenRx, an online pharmacy platform. By enabling an online pharmacy solution, people with diabetes now have another option to obtain POGO Automatic online in addition to physical pharmacy stores. FDA-cleared POGO Automatic Blood Glucose Monitoring (ABGM) system is the first and only automatic blood glucose monitoring system on the market offering easy-to-handle, all-in-one, and discreet glucose testing.

COLLABORATION PARTNERSHIP

#institution

#bgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES